Alyeska Investment Group
MANE

Alyeska Investment Group’s Veradermics Inc MANE Stock Holding History

Alyeska Investment Group’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.56M Buy
+61,521
New +$5.76M 0.02% 463

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Alyeska Investment Group's MANE Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Veradermics Inc (MANE) in Q2 2026: 61,521 shares worth $7.56M. The stake represents 0.02% of the portfolio and ranks #463 among its holdings.

164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Alyeska Investment Group held 61,521 shares of Veradermics Inc worth $7.56M as of Q2 2026.
  • Veradermics Inc was a new Alyeska Investment Group position in Q2 2026.
  • Veradermics Inc made up 0.02% of Alyeska Investment Group's portfolio in Q2 2026, its #463 holding.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.